| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/08/2007 | WO2005079768A3 Amoxicillin instant granulate |
| 03/08/2007 | WO2005039393A3 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 03/08/2007 | US20070055005 Method for forming nanocomposite materials |
| 03/08/2007 | US20070054943 Therapeutic agent for keratoconjunctival disorder |
| 03/08/2007 | US20070054878 Use of hyaluronic acid derivatives for inhibiting inflammatory arthritis |
| 03/08/2007 | US20070054845 Which block binding of polypeptides; treatment of metabolic disorders such as obesity, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/08/2007 | US20070053990 Pharmaceutical formulations exhibiting improved release rates |
| 03/08/2007 | US20070053989 Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents |
| 03/08/2007 | US20070053988 Monodispersed solid lipid particle compositions |
| 03/08/2007 | US20070053987 Cross-linked polysacharide and protein matrices and methods for their preparation |
| 03/08/2007 | US20070053986 System for the liberation of an active principle and its use |
| 03/08/2007 | US20070053985 Coenzyme Q10-containing fine particle with excellent dispersibility |
| 03/08/2007 | US20070053984 Topical gels compositions |
| 03/08/2007 | US20070053983 Extended release compositions of metoprolol succinate |
| 03/08/2007 | US20070053982 Sustained release oral formulations |
| 03/08/2007 | US20070053981 Solid composition comprising a proton pump inhibitor |
| 03/08/2007 | US20070053980 Extended release tiagabine formulations with reduced side-effects |
| 03/08/2007 | US20070053979 Controlled release formulation of erythromycin derivatives |
| 03/08/2007 | US20070053978 Process for co-spray drying liquid herbal extracts with dry silicified MCC |
| 03/08/2007 | US20070053977 Calcium carbonate granulation |
| 03/08/2007 | US20070053976 Synergistic donepezil hydrochloride and a selective serotonin reuptake inhibitor, milnacipran, or duloxetine administered seperately or concurrently |
| 03/08/2007 | US20070053975 Ramipril formulation |
| 03/08/2007 | US20070053974 Stable oral composition |
| 03/08/2007 | US20070053973 Amorphous antibiotic composition comprising cefditoren pivoxil |
| 03/08/2007 | US20070053972 Gelatin capsules containing actives |
| 03/08/2007 | US20070053971 Antimicrobial and Antiviral Compounds and Methods for their Use |
| 03/08/2007 | US20070053970 Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathway |
| 03/08/2007 | US20070053969 Device for treating and promoting healing of damaged body tissue |
| 03/08/2007 | US20070053968 Transdermal drug delivery devices containing O-Desmethyl Venlafaxine (ODV) or its salts |
| 03/08/2007 | US20070053967 Percutaneous absorption-type pharmaceutical preparations |
| 03/08/2007 | US20070053966 Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue |
| 03/08/2007 | US20070053965 Kit comprising a plaster, optionally containing an active substance, and an agent that at least partially reduces skin irritation |
| 03/08/2007 | US20070053964 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 03/08/2007 | US20070053963 Drug delivery to a joint |
| 03/08/2007 | US20070053959 Anti-perspirant/deodorant peel-on strip |
| 03/08/2007 | US20070053958 Elastomeric gloves and methods of making |
| 03/08/2007 | US20070053957 Agents for controlling biological fluids and methods of use thereof |
| 03/08/2007 | US20070053950 Composition of polymer microcapsules of biocide for coating material |
| 03/08/2007 | US20070053942 Disinfectant and/or bactericidal aqueous compositions |
| 03/08/2007 | US20070053940 Method of Measuring the Efficacy of a Skin Treatment Program |
| 03/08/2007 | US20070053939 Biguanide drug-containing jelly preparation |
| 03/08/2007 | US20070053930 Combination therapy for treatment of high cholesterol |
| 03/08/2007 | US20070053918 Injectable depots consisting of liposomal aggregates for the delivery of active substances |
| 03/08/2007 | US20070053895 Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
| 03/08/2007 | US20070053893 Method of reducing immunological tolerance to malignancy |
| 03/08/2007 | US20070053886 Biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
| 03/08/2007 | US20070053870 Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof |
| 03/08/2007 | US20070053849 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 03/08/2007 | US20070053846 Dry coating and downstream processing of cohesive powders |
| 03/08/2007 | US20070053845 Nanocell drug delivery system |
| 03/08/2007 | US20070053844 Formulations for alteration of biophysical properties of mucosal lining |
| 03/08/2007 | US20070053843 Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| 03/08/2007 | US20070053842 Method of engineering particles for use in the delivery of drugs via inhalation |
| 03/08/2007 | US20070053841 Use of 1,1,1,2-tetrafluoroethane for measuring lung function, especially for determining the functional residual capacity (frc) of the lungs |
| 03/08/2007 | DE10394357T5 Oro-dentale-Kräuterpflegezusammensetzung und Verfahren zur Herstellung derselben Oro-dental care herbal composition and method for producing the same |
| 03/08/2007 | DE102005041860A1 Nano-particle embedded- and charged-complex, useful for the production of a pharmaceutical composition, comprises two complex partners, where the complex partner is an embedded anionic and a cationic active substance |
| 03/08/2007 | DE10161149B4 Verwendung von Heparin-haltigem Ophthalmikum Use of heparin-containing ophthalmic |
| 03/08/2007 | CA2848021A1 Compostions and methods for preparation of poorly water soluble drugs with increased stability |
| 03/08/2007 | CA2621786A1 Polysaccharide microparticles containing biological agents: there preparation and applications |
| 03/08/2007 | CA2621377A1 Antitumor agent |
| 03/08/2007 | CA2621201A1 Topical formulations |
| 03/08/2007 | CA2621200A1 Transdermal active principle delivery means |
| 03/08/2007 | CA2621079A1 Dried milled granulate and methods |
| 03/08/2007 | CA2621037A1 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 03/08/2007 | CA2620687A1 Composition for diet comprising plant essential oil as active ingredient,sheet type composition for diet comprising thereof, percutaneous pharmaceutical agent for diet comprising thereof, and method for producing thereof |
| 03/08/2007 | CA2620685A1 Pharmaceutical composition comprising an iron chelator |
| 03/08/2007 | CA2620585A1 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| 03/08/2007 | CA2620400A1 Liposome compositions |
| 03/08/2007 | CA2620389A1 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 03/08/2007 | CA2619911A1 Pharmaceutical composition comprising perindopril or its salts |
| 03/08/2007 | CA2619676A1 Optically fluorescent nanoparticles |
| 03/08/2007 | CA2619438A1 Amorphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino(4,5-b) indole-1-acetamide |
| 03/08/2007 | CA2618996A1 Improvements in the stabilisation of biological materials |
| 03/08/2007 | CA2617920A1 Argatroban formulation comprising an acid as solubilizer |
| 03/08/2007 | CA2616515A1 Antihistamine- and corticosteroid- containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders |
| 03/08/2007 | CA2613474A1 Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds |
| 03/08/2007 | CA2609026A1 Formulations containing losartan and/or its salts |
| 03/07/2007 | EP1760467A1 Optically fluorescent nanoparticles |
| 03/07/2007 | EP1759726A2 Infusion pump with bolus estimator taking into account insulin sensitivity |
| 03/07/2007 | EP1759718A1 Tissue closing preparation |
| 03/07/2007 | EP1759713A2 Lock and key micelles |
| 03/07/2007 | EP1759712A2 Rapidly disintegrable pharmaceutical composition |
| 03/07/2007 | EP1759699A1 Liposome preparation containing slightly water-soluble camptothecin |
| 03/07/2007 | EP1759697A1 Pharmaceutical formulation containing at least two active principles |
| 03/07/2007 | EP1759693A2 Percutaneous absorption-type pharmaceutical preparations |
| 03/07/2007 | EP1759692A2 Taste-masked solid veterinary compositions |
| 03/07/2007 | EP1759691A1 Stable liposome compositions |
| 03/07/2007 | EP1759007A2 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 03/07/2007 | EP1758639A2 Infusion apparatus |
| 03/07/2007 | EP1758633A2 Methods for compounding and delivering a therapeutic agent to the adventitia of a vessel |
| 03/07/2007 | EP1758617A2 Stable liquid and lyophilized formulation of proteins |
| 03/07/2007 | EP1758616A1 Use in the medical, diagnostic and phlebological field of a mixture of sterile and physiologically acceptable gases |
| 03/07/2007 | EP1758612A2 Composition comprising intercalated functional-active organic compounds |
| 03/07/2007 | EP1758595A2 Use of lipid conjugates in the treatment of diseases |
| 03/07/2007 | EP1758591A1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology |
| 03/07/2007 | EP1758589A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
| 03/07/2007 | EP1758588A1 Pharmaceutical composition comprising an ointment and two solubilized active principles |
| 03/07/2007 | EP1758586A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase |
| 03/07/2007 | EP1758574A1 Pharmaceutical compositions containing polyunsaturated fatty acid and at least one of an immunosuppressive agent or an antineoplastic agent |
| 03/07/2007 | EP1758568A1 System and method for transdermal delivery of an anticoagulant |